Daily Coverage
Photo Gallery
Meeting Program
Registration
Archive
Home
Shifting the MIRV Timeline
New study highlights the possibilities of MIRV plus carboplatin in platinum-sensitive ovarian cancer.
Home
Cost-Saving and High Impact Primary HPV Testing
Home
SISTER: All for one and one for all?
Home
Treatment Shows Promise for Ovarian Clear Cell Carcinoma
SGO 2025
Save the date for SGO 2027 Annual Meeting on Women's Cancer
Home
A Clearer Signal in Ovarian Cancer
Data suggest longitudinal ctDNA tracking may sharpen response assessment and recurrence risk prediction.
Daily Coverage
Watch | SGO 2026 Annual Meeting Opening Ceremony
Advancing Science. Empowering Teams. Embracing Change.
Sponsored
Explore our DXd ADC Technology
At Daiichi Sankyo, we aim to expand the potential of antibody drug conjugates (ADCs) through our proprietary technology.
Home
Where Science Meets Community
Shared exhibit space at the SGO booth brings clinicians, researchers, and advocates together to tell the full story of gynecologic oncology.
Daily Coverage
Smile, You’re on Camera!
See Photo Gallery
Daily Coverage
ROSELLA Trial: Beyond Biomarkers
Trial results suggest a new standard in platinum-resistant ovarian cancer (PROC) therapy.
Interesting Stories
Sponsored by AbbVie
Step into new possibilities
Sponsored by Daiichi Sankyo
Explore our DXd ADC Technology
Sponsored by Verastem
Click here to learn more about Avmapki Fakzynja Co-Pack
Daily Coverage
Chemotherapy Followed by Endocrine Therapy Continues for Treatment of Low Grade Serous Ovarian Cancer
New science addresses a key clinical question about treating advanced-stage LGSOC.
Daily Coverage
Welcome to the SGO 2026 Annual Meeting on Women’s Cancer
SGO President Karen Lu, MD, reveals the three key components of this year’s theme.
SGO 2025
SGO 2026 Awards
High-caliber individuals are recognized for their work in research and service.
See the Award Winners
SGO 2025
2026 Research Awards and Donor Appreciation
23 men and women recognized for their important contributions in research.
See the Award Winners
SGO 2025
Meet SGO Incoming President, Matthew A. Powell, MD
Dr. Powell shares more about his background, new role, and plans for the upcoming year.
SGO 2025
Pembrolizumab Improves Survival in Platinum-Resistant Ovarian Cancer
The phase 3 ENGOT-ov65/KEYNOTE-B96 trial confirms the drug’s place in future therapies.
Daily Coverage
One-Two Punch for Gynecologic Oncology
Home
Hope on the Horizon
SGO 2025
A Perfect Place to Lounge and Lean in
Home
The Move Toward Personalized Fertility Sparing Treatment
Home
Building a Brighter Future
Home
Can Artificial Intelligence Save Real Time?
Daily Coverage
Breakthrough Science, Bold Conversations, and New Educational Experiences
Daily Coverage
Accreditation and Evaluations for CE
Daily Coverage
Bill Cliby, MD, Accepts the President's Award
Daily Coverage
Empowering Teams in San Juan
Daily Coverage
Embracing Change in San Juan
Daily Coverage
Explore the SGO 2026 Annual Meeting Schedule